Related Experiment Videos
Trends in CD4 Count Testing, Retention in Pre-ART Care, and ART Initiation Rates over the First Decade of Expansion
Serena P Koenig1,2, Daphne Bernard1, Jessy G Dévieux3
1Haitian Study Group for Kaposi's Sarcoma and Opportunistic Infections (GHESKIO), Port-au-Prince, Haiti.
Insights
Retention in HIV care improved significantly over a decade in Haiti, with more patients initiating antiretroviral therapy (ART). However, targeted efforts are still needed for individuals with higher CD4 counts to ensure consistent linkage to care.
Area of Science:
- Public Health
- Infectious Diseases
- HIV/AIDS Research
Background:
- High patient attrition from HIV testing to antiretroviral therapy (ART) initiation is a persistent global challenge.
- Despite expanded services and updated treatment guidelines, temporal trends in pre-ART care retention remain under-documented, hindering policy refinement.
Purpose of the Study:
- To evaluate temporal trends and identify predictors of patient retention at each stage from HIV testing to ART initiation.
- To analyze data over a decade at the GHESKIO clinic in Port-au-Prince, Haiti, to inform future public health strategies.
Main Methods:
- Retrospective analysis of 24,925 adult patients who tested HIV-positive between March 2003 and February 2013.
- Patients were followed for one year post-testing or until ART initiation, with data stratified by CD4 count.
Main Results:
- Significant improvements in CD4 count testing and ART initiation were observed over the decade, increasing from 36% to 78% for CD4 testing within 12 months.
- Retention in pre-ART care or ART initiation within one year improved across all CD4 strata, notably for those with CD4 counts ≤350 cells/mm³.
- Predictors of attrition included male gender, lower income, and lower education; older age and co-occurring tuberculosis were associated with better retention.
Conclusions:
- Patient retention and ART initiation have markedly increased over the past decade, especially for those with lower CD4 counts.
- While overall retention has improved, specific interventions are necessary to enhance care continuity for patients with higher CD4 counts.
Background:
High attrition during the period from HIV testing to antiretroviral therapy (ART) initiation is widely reported. Though treatment guidelines have changed to broaden ART eligibility and services have been widely expanded over the past decade, data on the temporal trends in pre-ART outcomes are limited; such data would be useful to guide future policy decisions.
Methods:
We evaluated temporal trends and predictors of retention for each step from HIV testing to ART initiation over the past decade at the GHESKIO clinic in Port-au-Prince Haiti. The 24,925 patients >17 years of age who received a positive HIV test at GHESKIO from March 1, 2003 to February 28, 2013 were included. Patients were followed until they remained in pre-ART care for one year or initiated ART.
Results:
24,925 patients (61% female, median age 35 years) were included, and 15,008 (60%) had blood drawn for CD4 count within 12 months of HIV testing; the trend increased over time from 36% in Year 1 to 78% in Year 10 (p<0.0001). Excluding transfers, the proportion of patients who were retained in pre-ART care or initiated ART within the first year after HIV testing was 84%, 82%, 64%, and 64%, for CD4 count strata ≤200, 201 to 350, 351 to 500, and >500 cells/mm3, respectively. The trend increased over time for each CD4 strata, and in Year 10, 94%, 95%, 79%, and 74% were retained in pre-ART care or initiated ART for each CD4 strata. Predictors of pre-ART attrition included male gender, low income, and low educational status. Older age and tuberculosis (TB) at HIV testing were associated with retention in care.
Conclusions:
The proportion of patients completing assessments for ART eligibility, remaining in pre-ART care, and initiating ART have increased over the last decade across all CD4 count strata, particularly among patients with CD4 count ≤350 cells/mm3. However, additional retention efforts are needed for patients with higher CD4 counts.
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections